KYNTRA BIO, INC.
KYNTRA BIO, INC.
SAN FRANCISCO, CA
Loading...
Price History
Market Data
| Market Cap | 16,160.00 |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 3.39 |
| Currency | USD |
Key Financial Metrics
6.44M
Revenue
183.45M
Net Income
-
EPS (Diluted)
13.26M
Free Cash Flow
Profitability
Gross Margin
91.4%
Operating Margin
-712.7%
Net Profit Margin
2848.6%
EBITDA
-45.90M
Returns & Efficiency
Return on Assets (ROA)
153.4%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-
Financial Health
Total Assets
119.59M
Total Debt
-
Debt to Equity
-
Current Ratio
3.39
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | SAN FRANCISCO, CA |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
935.08B
P/E: --
ELI LILLY & CO
LLY
935.08B
P/E: --
539.91B
P/E: --
ABBVIE INC.
ABBV
363.36B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.33B
P/E: --
MERCK & CO. INC.
MRK
281.33B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$16.16K
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin91.4%
Operating Margin-712.7%
Net Margin2848.6%
ROE-
ROA153.4%
Leverage & Liquidity
Debt to Equity-
Current Ratio3.39
Total Debt-
Total Assets$119.59M
Stockholders' Equity$-30.04M
Income Statement (FY 2025)
Revenue$6.44M
Gross Profit$5.88M
Operating Income$-45.90M
Net Income$183.45M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$13.26M
Cash & Equivalents$47.87M
Revenue Growth-78.3%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO, CA 94133 |
| Phone | N/A |
| Incorporated | , US |
| EIN | 770357827 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1,000.00 |
| Stockholders' Equity | $-30.04M |
| Cash & Equivalents | $47.87M |
Recent Filings
View All
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-27
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-27
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-27
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-09
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-11
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-12
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-25
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | KYNTRA BIO, INC. |
| Ticker | FGEN |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | SAN FRANCISCO, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 16,160.00 |
| Revenue | 6.44M |
| Net Income | 183.45M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 2848.6% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...